Rosine Vitman - Intermediate Capital Managing London
| ICG Stock | 2,094 18.00 0.87% |
Executive
Rosine Vitman is Managing London of Intermediate Capital Group
| Address | Procession House, London, United Kingdom, EC4M 7JW |
| Phone | 44 20 3545 2000 |
| Web | https://www.icgam.com |
Intermediate Capital Management Efficiency
The company has return on total asset (ROA) of 0.0515 % which means that it generated a profit of $0.0515 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2156 %, meaning that it generated $0.2156 on every $100 dollars invested by stockholders. Intermediate Capital's management efficiency ratios could be used to measure how well Intermediate Capital manages its routine affairs as well as how well it operates its assets and liabilities. At present, Intermediate Capital's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 1 B, whereas Other Current Assets are projected to grow to (1.4 B).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| FCA FCA | Target Healthcare REIT | N/A | |
| John Forrest | Spire Healthcare Group | N/A | |
| Vikas Gupta | Omega Healthcare Investors | 42 | |
| Angus Prentice | Spire Healthcare Group | N/A | |
| Andrew Buglass | Eco Animal Health | N/A | |
| Scott MA | Target Healthcare REIT | N/A | |
| Pr Grant | Spire Healthcare Group | 48 | |
| Philip Davies | Spire Healthcare Group | N/A | |
| Matthew Gourmand | Omega Healthcare Investors | 48 | |
| CA CA | Target Healthcare REIT | N/A | |
| Neal Ballew | Omega Healthcare Investors | 39 | |
| Gail JD | Omega Healthcare Investors | 49 | |
| Mathew Mason | Spire Healthcare Group | N/A | |
| Megan Krull | Omega Healthcare Investors | 46 | |
| Laura Towse | Abingdon Health Plc | N/A | |
| Mantraraj Budhdev | Spire Healthcare Group | 38 | |
| Peter Corfield | Spire Healthcare Group | N/A | |
| Matthew CPA | Omega Healthcare Investors | 48 | |
| Andrew Brown | Target Healthcare REIT | N/A | |
| Gail Makode | Omega Healthcare Investors | 49 | |
Management Performance
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0515 |
Intermediate Capital Leadership Team
Elected by the shareholders, the Intermediate Capital's board of directors comprises two types of representatives: Intermediate Capital inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intermediate. The board's role is to monitor Intermediate Capital's management team and ensure that shareholders' interests are well served. Intermediate Capital's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intermediate Capital's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chris Hunt, MD Relations | ||
| Rosine Vitman, Managing London | ||
| David Bicarregui, CFO Director | ||
| Andreas Mondovits, Senior Relations | ||
| Max Mitchell, Senior London | ||
| Alan CFA, Global Relations | ||
| Benoit Durteste, MD, CEO | ||
| Hadj Djema, Equity Europe | ||
| Sarah Faulkner, Chief Officer | ||
| Andrew Lewis, Global Secretary | ||
| Antje HenselRoth, Chief Director | ||
| Catherine Armstrong, Interim Communications |
Intermediate Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intermediate Capital a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0515 | ||||
| Profit Margin | 0.52 % | ||||
| Operating Margin | 0.56 % | ||||
| Current Valuation | 6.45 B | ||||
| Shares Outstanding | 290.63 M | ||||
| Shares Owned By Insiders | 1.40 % | ||||
| Shares Owned By Institutions | 70.70 % | ||||
| Price To Book | 2.59 X | ||||
| Price To Sales | 6.59 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Intermediate Stock
Intermediate Capital financial ratios help investors to determine whether Intermediate Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intermediate with respect to the benefits of owning Intermediate Capital security.